Article citationsMore>>

Lindermann, A., Brossart, P., Hoffken, K., et al. (1993) Immunomodulatory Effect of Ultra-Low-Dose Interleukin-2 in Cancer Patients: A Phase-1B Study. Cancer Immunotherapy, 37, 307.
https://doi.org/10.1007/BF01518453

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top